Alluvi 40MG pen
£105.00
Skip to product information
Alluvi 40MG pen
£105.00
Alluvi Retatrutide 40mg Pen is drawing global attention as a potential next-generation weight-loss injection.
Developed from Eli Lilly’s investigational molecule Retatrutide (LY3437943), it activates GLP-1, GIP, and glucagon receptors—three key pathways that influence appetite, metabolism, and energy balance
This product is sold for research purposes only